Axcelis Technologies, Inc. — Q1 2023 Form 10-Q
Reporting period: Three months ended March 31, 2023; comparisons are with the three months ended March 31, 2022, unless noted. Axcelis makes ion implantation equipment for semiconductor manufacturing and provides aftermarket products and services.
Financial performance
| Metric | Q1 2023 | Q1 2022 | Change |
|---|---|---|---|
| Revenue | $254.0 million | $203.6 million | +24.8% |
| Gross profit / margin | $104.0 million / 41.0% | $89.8 million / 44.1% | Profit +15.9%; margin down 3.1 percentage points |
| Operating income / margin | $51.4 million / 20.2% | $48.9 million / 24.1% | Income +5.0%; margin down 3.9 points |
| Net income | $47.7 million | $41.6 million | +14.6% |
| Diluted EPS | $1.43 | $1.22 | +17.2% |
| Operating cash flow | $34.6 million | $25.8 million | +$8.8 million |
- Revenue growth was led by systems: $195.2 million versus $151.8 million. Aftermarket revenue was $58.8 million versus $51.8 million.
- Product gross margin fell to 42.0% from 45.2%, primarily on a less favorable system-shipment mix and, to a lesser extent, higher supply-chain costs. Services gross margin declined to 9.8% from 12.4%, reflecting service-contract mix.
- Operating expenses rose 28.9% to $52.7 million, with R&D up 40.1% to $23.8 million. Management cited personnel costs, project materials and related services, and growth-support expenses.
- Other income was $1.5 million versus expense of $3.0 million, primarily reflecting a $3.8 million increase in interest income and a $0.6 million reduction in exchange losses. Income tax expense was $5.2 million; the effective tax rate was below the 21% U.S. statutory rate.
Balance sheet, liquidity and cash flow
- At March 31, 2023, cash and cash equivalents were $164.5 million, short-term investments $280.2 million, and restricted cash $6.7 million. Cash, cash equivalents and restricted cash totaled $171.1 million, down from $186.3 million at year-end 2022.
- Current assets were $934.4 million and current liabilities $267.9 million. Total liabilities were $378.0 million; stockholders’ equity was $701.8 million.
- Finance lease obligations totaled $46.1 million, including $1.3 million current. The filing reports no material borrowings under the revolving credit facility; the $40 million Silicon Valley Bank credit agreement was terminated on April 5, 2023, after quarter-end. A $5.9 million headquarters lease letter of credit had been converted to cash collateral and is included in restricted cash.
- Investing activities used $33.0 million, including $2.2 million of capital expenditures and net purchases of short-term investments. Financing activities used $16.7 million, including $12.5 million for share repurchases.
- Management stated that existing cash and cash equivalents should be sufficient for anticipated short- and long-term cash requirements. It also said cash is needed to support business growth and potential organic or inorganic opportunities.
Business trends, outlook and risks
- Management reported continued strong demand for capital equipment despite a downturn in memory, and improved—but not fully recovered—supply-chain performance. It said 89% of Q1 shipments went to mature foundry/logic customers.
- The filing provides no specific numerical revenue or earnings guidance. Results are subject to customer capital-spending and fab-utilization patterns and are not necessarily indicative of full-year results.
- Customer concentration is significant: the ten largest customers generated 64.7% of Q1 revenue; two customers represented 15.2% and 12.9% individually. Two customers accounted for 27.4% of accounts receivable at quarter-end.
- Deferred revenue increased to $201.7 million from $154.8 million at year-end, primarily because of advance customer payments. Inventory increased to $262.1 million from $242.4 million.
- The company repurchased 107,000 shares for $12.5 million during the quarter under its $100 million authorization; approximately $30.0 million remained available at March 31.
- Management reported no litigation believed likely to have a material adverse effect, no material changes to the risk factors in its 2022 Form 10-K, and effective disclosure controls. It recorded a $10.9 million U.S. valuation allowance against certain tax credits and state net operating losses.
Most important facts for investors to verify
- Whether system demand and the mix of shipments sustain revenue while gross margins recover from the quarter’s mix- and cost-related decline.
- How customer concentration, the memory downturn, and incomplete supply-chain recovery affect orders, deliveries, collections and deferred revenue conversion.
- The composition and availability of liquidity, including short-term investment maturities, restricted cash, and the impact of terminating the revolving credit agreement.
- Whether inventory growth and the $32.5 million of estimated future minimum payments for a signed but not yet commenced logistics and flex manufacturing facility align with demand and investment plans.
- The remaining repurchase authorization, capital needs, and the realization of deferred tax assets subject to future taxable income.